Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment?

dc.contributor.author	Bernabeu Morón, Ignacio
dc.contributor.author	Casanueva Freijo, Felipe
dc.date.accessioned	2017-06-07T07:02:28Z
dc.date.available	2017-06-07T07:02:28Z
dc.date.issued	2013
dc.identifier.issn	1355-008X
dc.identifier.uri	http://hdl.handle.net/20.500.11940/1951
dc.language.iso	eng
dc.title	Metabolic syndrome associated with hyperprolactinemia: a new indication for dopamine agonist treatment?
dc.type	Artigo	es
dc.authorsophos	Bernabeu, I.
dc.authorsophos	Casanueva, F. F.
dc.identifier.doi	10.1007/s12020-013-9914-1
dc.identifier.isi	325360800001
dc.identifier.pmid	23975607
dc.identifier.sophos	12452
dc.issue.number	2
dc.journal.title	ENDOCRINE
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Endocrinoloxía
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.page.initial	273
dc.page.final	4
dc.rights.accessRights	openAccess
dc.typesophos	Artículo de Opinión
dc.volume.number	44

Files in this item

Files	Size	Format	View
There are no files associated with this item.